Aterian (NASDAQ:ATER) Announces Earnings Results

Aterian (NASDAQ:ATER) issued its quarterly earnings results on Monday. The company reported ($0.97) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.58) by ($0.39), FiscalAI reports. Aterian had a negative return on equity of 47.45% and a negative net margin of 15.73%.The business had revenue of $15.13 million for the quarter, compared to analyst estimates of $18.38 million.

Aterian Trading Up 1.7%

Shares of NASDAQ ATER opened at $0.60 on Monday. The firm has a market capitalization of $6.02 million, a P/E ratio of -0.37 and a beta of 0.02. The firm’s 50-day moving average price is $0.65 and its 200-day moving average price is $0.80. Aterian has a 1-year low of $0.52 and a 1-year high of $2.56.

Institutional Investors Weigh In On Aterian

Hedge funds and other institutional investors have recently modified their holdings of the company. Susquehanna International Group LLP grew its position in Aterian by 310.2% in the 3rd quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock valued at $43,000 after purchasing an additional 30,637 shares during the period. Citadel Advisors LLC raised its stake in shares of Aterian by 222.0% in the third quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock worth $35,000 after purchasing an additional 22,865 shares during the last quarter. XTX Topco Ltd bought a new position in shares of Aterian in the second quarter valued at approximately $55,000. Finally, Goldman Sachs Group Inc. lifted its holdings in shares of Aterian by 73.0% in the first quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after purchasing an additional 9,026 shares in the last quarter. Institutional investors own 7.02% of the company’s stock.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aterian in a research note on Wednesday, January 21st. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Reduce”.

Aterian Company Profile

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.